Clinical Trial Update: Targeting Microvascular Dysfunction in Young Hypertensive Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial targeting microvascular dysfunction in young hypertensive patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Queen's University, Belfast | Conditions: Hypertension | Phase 4 | Status: WITHDRAWN